★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Agilent Technologies, Inc. vs Thermo Fisher Scientific Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Agilent Technologies, Inc.

A · New York Stock Exchange

Market cap (USD)$44.9B
Gross margin (TTM)53%
Operating margin (TTM)21.5%
Net margin (TTM)19.6%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
Data as of2026-08-23
Moat score
79/ 100

Partial score covering 81% of segment weight.

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Agilent Technologies, Inc.'s moat claims, evidence, and risks.

View A analysis

Thermo Fisher Scientific Inc.

TMO · New York Stock Exchange

Market cap (USD)$233.8B
Gross margin (TTM)40.4%
Operating margin (TTM)17.7%
Net margin (TTM)15.1%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
Data as of2026-08-23
Moat score
59/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Thermo Fisher Scientific Inc.'s moat claims, evidence, and risks.

View TMO analysis

Comparison highlights

  • Segment focus: Agilent Technologies, Inc. has 3 segments (41.9% in Agilent CrossLab); Thermo Fisher Scientific Inc. has 4 segments (55.5% in Laboratory Products and Biopharma Services).
  • Primary market structure: Competitive vs Competitive. Pricing power: Strong vs Moderate.
  • Moat breadth: Agilent Technologies, Inc. has 4 moat types across 2 domains; Thermo Fisher Scientific Inc. has 3 across 2.

Primary market context

Agilent Technologies, Inc.

Agilent CrossLab

Market

Laboratory services, compliance/maintenance, consumables and lab informatics across the lab workflow

Geography

Global

Customer

B2B (installed base labs across pharma, diagnostics, academia and applied markets)

Role

Aftermarket services + consumables + informatics

Revenue share

41.9%

Thermo Fisher Scientific Inc.

Laboratory Products and Biopharma Services

Market

Laboratory supplies distribution/market channel plus outsourced biopharma services (CDMO/CRO)

Geography

Global

Customer

Pharma & biotech; academic/government labs; industrial and clinical laboratories

Role

Distributor/market channel and outsourced services provider

Revenue share

55.5%

Side-by-side metrics

Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Ticker / Exchange
A - New York Stock Exchange
TMO - New York Stock Exchange
Market cap (USD)
$44.9B
$233.8B
Gross margin (TTM)
53%
40.4%
Operating margin (TTM)
21.5%
17.7%
Net margin (TTM)
19.6%
15.1%
Sector
Healthcare
Healthcare
Industry
Medical - Diagnostics & Research
Medical - Diagnostics & Research
HQ country
US
US
Primary segment
Agilent CrossLab
Laboratory Products and Biopharma Services
Market structure
Competitive
Competitive
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Strong
Moderate
Moat score
79 / 100 (partial, 81% coverage)
59 / 100
Moat domains
Demand, Supply
Demand, Supply
Last update
2026-08-23
2026-08-23

Moat coverage

Shared moat types

Installed Base Consumables

Agilent Technologies, Inc. strengths

Design In QualificationService Field NetworkData Workflow Lockin

Thermo Fisher Scientific Inc. strengths

Distribution ControlProcurement Inertia

Segment mix

Agilent Technologies, Inc. segments

Full profile >

Life Sciences and Diagnostics Markets

Oligopoly

39.2%

Agilent CrossLab

Competitive

41.9%

Applied Markets

Oligopoly

18.9%

Thermo Fisher Scientific Inc. segments

Full profile >

Life Sciences Solutions

Oligopoly

19.6%

Analytical Instruments

Oligopoly

15%

Specialty Diagnostics

Oligopoly

9.9%

Laboratory Products and Biopharma Services

Competitive

55.5%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like A and TMO, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.